Previous Section
Clinical Trials
41. Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer.
- Author
- Rosell R; Robinet G; Szczesna A; Ramlau R; Constenla M; Mennecier BC; Pfeifer W; O'Byrne KJ; Welte T; Kolb R; Pirker R; Chemaissani A; Perol M; Ranson MR; Ellis PA; Pilz K; Reck M;
- Institution
- Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain. rrosell@ico.scs.es
- Journal
- Ann Oncol. 2008 Feb;19(2):362-9. Epub 2007 Oct 17.
- Abstract URL
- Click here to view abstract
42. Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer.
- Author
- Socinski MA; Novello S; Brahmer JR; Rosell R; Sanchez JM; Belani CP; Govindan R; Atkins JN; Gillenwater HH; Pallares C; Tye L; Selaru P; Chao RC; Scagliotti GV;
- Institution
- Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina, CB# 7305, Chapel Hill, NC 27599, USA. socinski@med.unc.edu
- Journal
- J Clin Oncol. 2008 Feb 1;26(4):650-6.
- Abstract URL
- Click here to view abstract
43. Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib.
- Author
- Cho BC; Im CK; Park MS; Kim SK; Chang J; Park JP; Choi HJ; Kim YJ; Shin SJ; Sohn JH; Kim H; Kim JH;
- Institution
- Yonsei Cancer Center, Seoul, Korea.
- Journal
- J Clin Oncol. 2007 Jun 20;25(18):2528-33.
- Abstract URL
- Click here to view abstract
44. Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide.
- Author
- Bolonaki I; Kotsakis A; Papadimitraki E; Aggouraki D; Konsolakis G; Vagia A; Christophylakis C; Nikoloudi I; Magganas E; Galanis A; Cordopatis P; Kosmatopoulos K; Georgoulias V; Mavroudis D;
- Institution
- Department of Transfusion Medicine, University General Hospital of Heraklion, Heraklion, Crete, Greece.
- Journal
- J Clin Oncol. 2007 Jul 1;25(19):2727-34.
- Abstract URL
- Click here to view abstract
45. Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy.
- Author
- Vansteenkiste J; Lara PN Jr; Le Chevalier T; Breton JL; Bonomi P; Sandler AB; Socinski MA; Delbaldo C; McHenry B; Lebwohl D; Peck R; Edelman M;
- Institution
- Respiratory Oncology Unit, University Hospital Gasthuisberg, Leuven, Belgium. johan.vansteenkiste@uz.kuleuven.ac.be
- Journal
- J Clin Oncol. 2007 Aug 10;25(23):3448-55. Epub 2007 Jul 2.
- Abstract URL
- Click here to view abstract
46. A prospective phase II study of a new treatment protocol for NSCLC combined with preoperative mediastinoscopy and chemotherapy.
- Author
- Nakajima T; Kimura H; Suzuki M; Wada H; Ando S; Iida T; Sekine Y; Fujisawa T;
- Institution
- Department of Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Journal
- Thorac Cardiovasc Surg. 2007 Aug;55(5):317-21.
- Abstract URL
- Click here to view abstract
47. Combination therapy with gefitinib and rofecoxib in patients with platinum-pretreated relapsed non small-cell lung cancer.
- Author
- O'Byrne KJ; Danson S; Dunlop D; Botwood N; Taguchi F; Carbone D; Ranson M;
- Institution
- St James's Hospital, Dublin, Ireland. kobyrne@stjames.ie
- Journal
- J Clin Oncol. 2007 Aug 1;25(22):3266-73.
- Abstract URL
- Click here to view abstract
48. Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer.
- Author
- Janne PA; von Pawel J; Cohen RB; Crino L; Butts CA; Olson SS; Eiseman IA; Chiappori AA; Yeap BY; Lenehan PF; Dasse K; Sheeran M; Bonomi PD;
- Institution
- Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute and Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA. pjanne@partners.org
- Journal
- J Clin Oncol. 2007 Sep 1;25(25):3936-44.
- Abstract URL
- Click here to view abstract
49. Phase I trial of sirolimus combined with radiation and cisplatin in non-small cell lung cancer.
- Author
- Sarkaria JN; Schwingler P; Schild SE; Grogan PT; Mladek AC; Mandrekar SJ; Tan AD; Kobayashi T; Marks RS; Kita H; Miller RC; Limper AH; Leof EB;
- Institution
- Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA. sarkaria.jann@mayo.edu
- Journal
- J Thorac Oncol. 2007 Aug;2(8):751-7.
- Abstract URL
- Click here to view abstract
50. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
- Author
- Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R;
- Institution
- Gravina Hospital, Oncology Unit, Caltagirone, Italy.
- Journal
- Anticancer Drugs. 2007 Jul;18(6):713-9.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
